The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1

BACKGROUND: Heat shock protein 90 (HSP90) inhibitors have emerged as a promising class of anti-cancer drugs in both solid and hematologic malignancies. The HSP90 family includes the cytosolic HSP90 (HSP90AA1), the ER paralogue gp96 (HSP90B1) and the mitochondrial member TRAP1 (HSP90L). We evaluated...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Usmani, Saad Z, Bona, Robert D, Chiosis, Gabriela, Li, Zihai
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2010
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2974653/
https://ncbi.nlm.nih.gov/pubmed/20977755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-3-40
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares